|
Organizational Overview
The Transfusion Medicine Hemostasis Clinical
Trial Network is funded through the National Heart,
Lung and Blood Institute (NHLBI), the National
Heart, Lung, and Blood Institute at the National
Institutes of Health (NIH).
The Data Coordinating Center (DCC) plays a key
role in developing and facilitating study protocols
and is responsible for statistical planning and
accumulation of quality data from participating
clinical centers. The DCC for the TMH Network
is New England Research Institutes, Inc., at www.neriscience.com
There are 17 Core
Clinical Centers (some of which are consortia
of two or more centers) with cooperative agreements
from the NHLBI to participate in the TMH Network.
Additional non-Core Centers may also participate
in TMH Network trials through subcontracts with
the DCC.
Contact Information
NHLBI/NIH:
George Nemo, PhD - Project Officer
Division of Blood Diseases and Resources
National Heart, Lung, and Blood Institute; National
Institutes of Health
6701 Rockledge Drive
Rockledge II, Room 10142
Bethesda, MD 20817
phone: (301) 435-0074
fax: (301) 480-0868
Email: nemog@nhlbi.nih.gov
Data Coordinating Center:
Susan Assmann, PhD
New England Research Institutes, Inc.
9 Galen Street, Suite 117
Watertown, MA 02472
phone: (617) 923-7747 ext.548
fax: (617) 926-8246
Email: sassmann@neriscience.com
TMH Network Steering Committee Chair
M.A. Blajchman, MD, FRCP(C)
Chair, NHLBI TMH CTN Steering Committee
Professor Emeritus, Departments of Pathology and Medicine
McMaster University
1200 Main St. W., HSC-4N67
Hamilton, ON, Canada L8N 3Z5
(905) 525-9140 Ext. 26276;
(905)-527-4866 (FAX)
Email: blajchma@mcmaster.ca
|
